Early identification and high-risk strategies for bipolar disorder.
OBJECTIVE
To describe and compare the relative merits of different identification strategies for individuals at risk for bipolar disorder (BPD).


METHODS
Selective review of data that support early identification in BPD, with a particular focus on emerging clinical high-risk strategies.


RESULTS
Early detection of individuals at risk for BPD can utilize genetic, endophenotypic and clinical methods. Most published work focuses on genetic familial endophenotypic risk markers for BPD. However, despite encouraging results, problems with specificity and sensitivity limit the application of these data to early prevention programs. In addition, offspring studies of BPD patients systematically exclude the majority of subjects without a first-degree bipolar relative. On the other hand, emerging work in the clinical-high-risk arena has already produced encouraging results. Although still preliminary, the identification of individuals in subsyndromal or attenuated symptom 'prodromal' stages of BPD seems to be an under-researched area that holds considerable promise deserving increased attention. Required next steps include the development of rating tools for attenuated and subsyndromal manic and depressive symptoms and of prodromal criteria that will allow prodromal symptomatology to be systematically studied in patients with recent-onset bipolar, as well as in prospective population-based phenomenology trials and attenuated symptom-based high-risk studies.


CONCLUSIONS
Given the current limitations of each early identification method, combining clinical, endophenotypic and genetic strategies will increase prediction accuracy. Since reliable biological markers for BPD have not been established and since most patients with BPD lack a first-degree relative with this disorder, clinical high-risk approaches have great potential to inform early identification and intervention programs.
Correll
Christoph U
CU
The Zucker Hillside Hospital, Psychiatry Research, North Shore - Long Island Jewish Health System, Glen Oaks, NY 11004, USA. ccorrell@lij.edu
Penzner
Julie B
JB
Lencz
Todd
T
Auther
Andrea
A
Smith
Christopher W
CW
Malhotra
Anil K
AK
Kane
John M
JM
Cornblatt
Barbara A
BA
D001714:Bipolar Disorder / Q000175:diagnosis* / Q000235:genetics / Q000523:psychology; D042241:Early Diagnosis; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005838:Genotype; D006801:Humans; D010641:Phenotype; D012307:Risk Factors